Alcon AG | ALC - Loan Capital


Alcon AG reported $4.16B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
AstraZeneca USD 25.96B 177M Mar/2026
Bayer EUR 30.68B 1.15B Mar/2026
Essilor EUR 9.46B 92M Dec/2025
Fresenius EUR 9.22B 1.58B Dec/2025
Fresenius Medical Care EUR 5.74B 895.27M Mar/2026
GlaxoSmithKline GBP 14.01B 696M Mar/2026
GRIFOLS EUR 9.08B 612M Mar/2026
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.8B 72M Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Philips EUR 6.89B 43M Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
Smith & Nephew USD 3.3B 22M Dec/2025
Sonova Holding CHF 1.39B 209.8M Jun/2025
UCB EUR 2.18B 634M Dec/2025